Ratings by Oppenheimer (Steven M. Lichtman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/10/2025 | AngioDynamics | ANGO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/4/2024 | AngioDynamics | ANGO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/16/2024 | AngioDynamics | ANGO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/5/2024 | AngioDynamics | ANGO | Upgrade | Outperform (Perform) |
6.40 (10.83) |
69.22% | Details | |
| 8/20/2021 | AngioDynamics | ANGO | New Coverage | Perform (N/A) |
26.95 (6.40) |
-76.25% | Details |
